Paper5483885
Experimental allergic encephalomyelitis. Antiserum inhibition of myelination in vitro.
Bornstein MB and 1 other. Lab Invest, 1970. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Experimental allergic encephalomyelitis. Antiserum inhibition of myelination in vitro. Papers, record 5483885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5483885
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement System Proteins | Major topic |
| Encephalomyelitis, Autoimmune, Experimental | Major topic |
| Immune Sera | Major topic |
| Myelin Sheath | Major topic |
| Animals | |
| Cell Differentiation | |
| Culture Techniques | |
| Ganglia, Spinal | |
| Mice | |
| Neuroglia | |
| Rabbits |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31544855 | Myelin Antigens and Antimyelin Antibodies. | Antibodies (Basel) | 2018 | https://conductscience.org/library/papers/31544855 | PubMed |
| 11145196 | The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. | Brain Pathol | 2001 | https://conductscience.org/library/papers/11145196 | PubMed |
| 8391270 | Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. | Mol Neurobiol | 1993 | https://conductscience.org/library/papers/8391270 | PubMed |
| 7445973 | Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis. | Acta Neuropathol | 1980 | https://conductscience.org/library/papers/7445973 | PubMed |
| 6209241 | Rat CNS cell culture. Enhancement of neuronal survival and delay of glial proliferation by serum from patients with multiple sclerosis. A morphological study. | Ital J Neurol Sci | 1984 | https://conductscience.org/library/papers/6209241 | PubMed |
| 4727738 | Experimental allergic encephalomyelitis (EAE): delayed myelination-inhibition in vitro with EAE-serum: changes in vulnerability of oligodendroglia and newly formed myelin sheaths. | Acta Neuropathol | 1973 | https://conductscience.org/library/papers/4727738 | PubMed |
| 4567443 | Multiple sclerosis. Current etiological concepts. | Calif Med | 1972 | https://conductscience.org/library/papers/4567443 | PubMed |
| 3889690 | Double ligand ELISA technique for the estimation of antibodies to brain tissue antigens in patients with neurological disorders. | Neurochem Res | 1985 | https://conductscience.org/library/papers/3889690 | PubMed |
| 77321 | Multiple sclerosis: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases. | J Neurol | 1978 | https://conductscience.org/library/papers/77321 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5483885
GET https://conductscience.org/api/papers/v1/5483885/authors